Lonza Completes Acquisition of InterHealth Nutraceuticals

Lonza closed the acquisition of InterHealth Nutraceuticals from Kainos Capital, with InterHealth becoming part of Lonza's Consumer Care Business Unit, for a total transaction price of up to US$300 million.

September 13, 2016

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

Lonza closed the acquisition of InterHealth Nutraceuticals from Kainos Capital, with InterHealth becoming part of Lonza's Consumer Care Business Unit, for a total transaction price of up to US$300 million.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like